|
VENUS I
|
VENUS II
|
---|
UFS-QOL
|
Bleeding daysa
|
Heavy bleeding daysb
|
Bleeding daysa
|
Heavy bleeding daysb
|
PGI-I
|
---|
Symptom Severity
|
0.59
|
0.56
|
0.62
|
0.60
|
0.69
|
Concern
|
−0.61
|
−0.58
|
−0.63
|
−0.63
|
−0.70
|
Activities
|
−0.63
|
−0.63
|
−0.54
|
−0.58
|
−0.67
|
Revised Activities
|
−0.63
|
−0.63
|
−0.53
|
−0.57
|
−0.66
|
Energy/Mood
|
−0.56
|
−0.58
|
−0.44
|
−0.51
|
−0.57
|
Control
|
−0.49
|
−0.54
|
−0.46
|
−0.52
|
−0.58
|
Self-Consciousness
|
−0.43
|
−0.41
|
−0.42
|
−0.47
|
−0.53
|
Sexual Function
|
−0.44
|
−0.47
|
−0.35
|
−0.40
|
−0.48
|
HRQoL Total
|
−0.61
|
−0.62
|
−0.53
|
−0.58
|
−0.66
|
- All p < 0.0001
- aNumber of days in previous 35 days – “bleeding”: days with rating of “bleeding” and “heavy bleeding”
- b“Heavy bleeding”: days with rating of “heavy bleeding”. HRQoL health-related quality of life; PGI-I Patient Global Impression of Improvement scale; UFS-QOL Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire